Advisory Services Network’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8K Buy
+739
New +$27.6K ﹤0.01% 2955
2025
Q4
Sell
-300
Closed -$24.9K 2298
2025
Q3
$24.9K Buy
+300
New +$21.7K ﹤0.01% 2841
2025
Q2
Sell
-7,032
Closed -$803K 1759
2025
Q1
$803K Sell
7,032
-8,626
-55% -$525K 0.02% 860
2024
Q4
$789K Sell
15,658
-4,976
-24% -$261K 0.01% 842
2024
Q3
$670K Hold
20,634
0.01% 862
2024
Q2
$670K Buy
20,634
+3,898
+23% +$107K 0.01% 862
2024
Q1
$422K Buy
16,736
+16,472
+6,239% +$389K 0.01% 1019
2023
Q4
$8.57K Buy
+264
New +$7.25K ﹤0.01% 2924
2023
Q2
Sell
-3,004
Closed -$65.1K 1881
2023
Q1
$65.1K Buy
3,004
+2,781
+1,247% +$61K ﹤0.01% 1885
2022
Q4
$4.53K Buy
+223
New +$5.59K ﹤0.01% 3161
2021
Q3
Sell
-200
Closed -$4K 1760
2021
Q2
$4K Buy
+200
New +$4.45K ﹤0.01% 3121
2021
Q1
Sell
-200
Closed -$5K 1602
2020
Q4
$5K Hold
200
﹤0.01% 2694
2020
Q3
$3K Buy
+200
New +$3.19K ﹤0.01% 2927
2019
Q1
Sell
-609
Closed -$8K 2545
2018
Q4
$8K Buy
609
+547
+882% +$7.23K ﹤0.01% 1825
2018
Q3
$1K Hold
62
﹤0.01% 2372
2018
Q2
$1K Buy
62
+15
+32% +$261 ﹤0.01% 2339
2018
Q1
$1K Buy
+47
New +$871 ﹤0.01% 2455

Other funds holding CORT

Advisory Services Network's CORT Position: Q1 2026 in Review

Advisory Services Network opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 739 shares worth $29.8K. The stake represents ﹤0.01% of the portfolio and ranks #2955 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CORT as recently as Q3 2025.

Advisory Services Network first reported a position in CORT in Q1 2018 and has held it in 17 quarters since. The position peaked at $803K in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Advisory Services Network held 739 shares of Corcept Therapeutics worth $29.8K as of Q1 2026.
  • Corcept Therapeutics was a new Advisory Services Network position in Q1 2026.
  • Corcept Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2955 holding.
  • Advisory Services Network first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 17 quarters since.
  • Advisory Services Network's Corcept Therapeutics position peaked at $803K in Q1 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.